natgillin/translations-raw huggingface dataset:
At brugen af Viread bør undgås med samtidig eller nylig brug af nefrotoksiske lægemidler.
That use of Viread should be avoided with concomitant or recent use of nephrotoxic medicinal products.
At børn kan have en øget risiko for at udvikle infektioner og nødvendigheden af, at vaccinationer er opdateret.
That children may be at increased risk of developing infections and that their immunisations need to be up to date.
At børn kan have en øget risiko for at udvikle infektioner, og at de skal have fået alle deres anbefalede vaccinationer.
That children may be at increased risk of developing infections and that their immunisations need to be up-to-date.
At børn kan have en øget risiko for at udvikle infektioner, og at deres vaccinationer skal være up to date.
That children may be at increased risk of developing infections and that their immunisations need to be up to date.
At børn kan have en øget risiko for at udvikle infektioner, og at deres vaccinationer skal være up to date.
That children may be at increased risk of developing infections and that their immunisations need to be up-to-date.
At Cubicin kan interferere med koagulationstest (PT/INR), hvilket kan medføre falske resultater.
That Cubicin can interfere with coagulation tests (PT/INR) and this might lead to false results.
at de ikke må donere organer, blod og celler
not to donate organs nor blood nor cells
At de skal kontakte deres læge for yderligere informationer;
That they should consult their healthcare provider for further information;
At deferasirox forårsager stigninger i serum-kreatinin hos visse patienter
That deferasirox causes rises in serum creatinine in some patients
At den dosis der nyligst er anbefalet af deres læge altid skal følges;
That the dose newly recommended by their healthcare provider should always be followed;
at den fyldte injektionssprøjte ikke er beskadiget
the pre-filled syringe is not damaged
at den fyldte injektionssprøjte ikke er beskadiget.
the pre-filled syringe is not damaged
at den ikke har overskredet udløbsdatoen
it has not passed its expiry date
at den sterile indre blisterpakning åbnes af en steril person at anvende TachoSil hurtigst muligt efter åbning af den ydre alufoliepakning. at TachoSil tages i brug straks efter åbningen af den indre, sterile blisterpakning.
to have a sterile person open the inner sterile package to use TachoSil soon after opening the outer aluminium cover. to use TachoSil immediately after opening the inner sterile package.
at den sygdom, som lægemidlet er beregnet til at fremkalde immunitet mod, stort set ikke forekommer i det pågældende område.
the disease to which the product is intended to confer immunity is largely absent from the territory in question.
at den sygdom, som lægemidlet er beregnet til at fremkalde immunitet mod, stort set ikke forekommer i det pågældende område.
the disease to which the veterinary medicinal product is intended to confer immunity is largely absent from the territory.
at den sygdom, som veterinærlægemidlet er beregnet til at fremkalde immunitet mod, stort set ikke forekommer i det pågældende område.
the disease to which the product is intended to confer immunity is largely absent from the territory in question
at den sygdom, som veterinærlægemidlet er beregnet til at fremkalde immunitet mod, stort set ikke forekommer i det pågældende område.
the disease to which the product is intended to confer immunity is largely absent from the territory in question.
at den sygdom, som veterinærlægemidlet er beregnet til at fremkalde immunitet mod, stort set ikke forekommer i det pågældende område.>
the disease to which the product is intended to confer immunity is largely absent from the territory in question.
at den sygdom, som veterinærlægemidleter beregnet til at fremkalde immunitet mod, stort set ikke forekommer i det pågældende område.
the disease to which the product is intended to confer immunity is largely absent from the territory in question.
at den ydre alufoliepakning åbnes af en ikke-steril person
to have a non-sterile person open the outer aluminium cover
At der anbefales en multidisciplinær fremgangsmåde for behandlingen af pædiatriske patienter
That a multidisciplinary approach is recommended for the management of paediatric patients
At der dannes suspension skyldes, at nogle af hjælpestofferne i Ebilfumin-kapslerne, er uopløselige).
The suspension is caused by some of the excipients of Ebilfumin capsules, which are insoluble.)
At der dannes suspension skyldes, at nogle af hjælpestofferne i Tamiflu- kapslerne, er uopløselige.
The suspension is caused by some of the excipients of Tamiflu capsules, which are insoluble.)
At der er en identificeret risiko for ototoksicitet, og patienter, der udvikler tegn eller symptomer på ototoksicitet, eller patienter, der får andre medicinprodukter med ototoksisk potentiale, bør omhyggeligt evalueres og overvåges.
That there is an identified risk of ototoxicity and patients developing ototoxicity signs or symptoms or patients receiving other medicinal products with ototoxic potential should be carefully evaluated and monitored.
At der er en interaktion med hormonelle præventionsmidler
That there is an interaction with hormonal contraceptives
At der er en potentiel risiko for teratogenicitet, og at Vibativ er kontraindiceret under graviditet.
That there is a potential risk of teratogenicity and Vibativ is contraindicated during pregnancy.
At der er en risiko for infusionsrelaterede reaktioner, herunder ’red man syndrome-lignende’ reaktioner.
That there is a risk of infusion related reactions including red man syndrome-like reactions.
At der er en øget risiko for nyresygdom hos hiv- og HBV-inficerede patienter forbundet med tenofovirdisoproxilfumarat-indeholdende præparater, såsom Viread
That there is an increased risk of renal disease in HIV and HBV infected patients associated with tenofovir disoproxil fumarate-containing products such as Viread
At der er en øget risiko for nyresygdom hos hiv-inficerede patienter forbundet med tenofovirdisoproxilfumarat-indeholdende præparater, såsom Atripla
That there is an increased risk of renal disease in HIV infected patients associated with tenofovir disoproxil fumarate-containing products such as Atripla
At der er en øget risiko for nyresygdom hos hiv-inficerede patienter i forbindelse med præparater som Emtricitabine/Tenofovir disoproxil Zentiva, der indeholder tenofovirdisoproxil
That there is an increased risk of renal disease in HIV infected patients associated with tenofovir disoproxil-containing products such as Emtricitabine/Tenofovir disoproxil Zentiva
At der er en øget risiko for nyresygdom hos HIV-inficerede patienter i forbindelse med præparater som Truvada, der indeholder tenofovirdisoproxilfumarat
That there is an increased risk of renal disease in HIV infected patients associated with tenofovir disoproxil fumarate-containing products such as Truvada
At der er interaktion med ciclosporin, som kan medføre højere blodkoncentrationer af Thelin og således en øget risiko for bivirkninger.
That there is an interaction with ciclosporin A which may lead to higher blood concentration of Thelin and hence an increased risk of adverse reactions.
At der er interaktion med hormonale præventionsmidler
That there is an interaction with hormonal contraceptives
At der er rapporteret overfølsomhedsreaktioner for Volibris (f.eks. angioødem, udslæt) med hyppigheden ’ikke almindelig’ i kliniske korttidsstudier og ’almindelig’ i kliniske langtidsstudier og i kombination med tadalafil.
That hypersensitivity reactions (e.g. angioedema, rash), although uncommon in short term clinical trials and common in longer term trials and in combination with tadalafil, have been reported with Volibris.
At der er risiko for alvorlig leverskade, og at det derfor er vigtigt regelmæssigt at måle ALAT for at overvåge leverfunktionen.
That there is a risk of severe liver injury and so regular measurement of ALT (SGPT ) levels to monitor liver function is important.
At der er risiko for alvorlig leverskade, og at det derfor er vigtigt regelmæssigt at måle ALAT for at overvåge leverfunktionen.
That there is a risk of severe liver injury and so regular measurement of ALT (SGPT) levels to monitor liver function is important.
At der er risiko for alvorlig skeletmuskeltoksicitet, og at det derfor er vigtigt at måle kreatinkinase (CK), før behandlingen startes og regelmæssigt derefter.
That there is a risk of severe skeletal muscle toxicity and so measuring the CPK at treatment initiation and at regular intervals is important.
At der er risiko for teratogen effekt og at svangerskab derfor skal undgås, indtil plasmakoncentrationen af leflunomid er på et passende niveau.
That there is a risk of teratogenicity and so pregnancy must be avoided until leflunomide plasma levels are at an appropriate level.
At der er risiko for teratogen effekt og at svangerskab derfor skal undgås, indtil plasmakoncentrationen af leflunomid er på et passende niveau.
That there is a risk of teratogenicity and so pregnancy must be avoided until leflunomide plasma levels are at an appropriatelevel.
at der ikke er nok af den rigtige type celler til at fremstille produktet.
not enough of the right type of cells to manufacture the medicine.
at der ikke skal administreres mere end to injektioner hydroxocobalamin,
that no more than two injections of hydroxocobalamin are to be administered,
At der kan være risiko for teratogenicitet, og derfor skal Eurartesim ikke anvendes i situationer, hvor andre hensigtsmæssige og effektive midler mod malaria er tilgængelige.
That there is a potential risk of teratogenicity and so Eurartesim should not be used in situations where other suitable and effective anti-malarials are available.
At der kommer luft i insulinbeholderen og lækage af insulin, som kan medføre forkert dosering
Entry of air into the insulin reservoir and leakage of insulin, which can cause inaccurate dosing.
At der kommer luft i insulinbeholderen og lækage af insulin, som kan medføre forkert dosering.
Entry of air into the insulin reservoir and leakage of insulin, which can cause inaccurate dosing.
At der skal optages baseline-ekg og måles blodtryk før den første dosis af Gilenya.
That they will have a baseline ECG and blood pressure measurement prior to the first dose of GILENYA.
At der skal udvises forsigtighed ved anvendelse af Trobalt hos patienter med hjertesygdom eller patienter, der samtidig tager lægemidler, der er kendt for at forlænge QT-intervallet.
Caution when using TROBALT in patients with a cardiac disease or those taking medicines concomitantly known to cause QT prolongation
At der udføres et studie for at indsamle information om lægemidlets sikkerhed og for at monitorere den hensigtsmæssige anvendelse, samt at MDS-patienter skal inkluderes i studiet, før behandlingen med Revlimid påbegyndes
That a study is being conducted to collect information regarding the safety of the drug and to monitor its appropriate use; and that MDS patients should be included in the study prior to the start of the treatment with Revlimid
At det bør undgås at anvende Emtricitabine/Tenofovir disoproxil Zentiva samtidig med eller efter nylig brug af nefrotoksiske lægemidler.
That use of Emtricitabine/Tenofovir disoproxil Zentiva should be avoided with concomitant or recent use of nephrotoxic medicinal products.
At det bør undgås at anvende Truvada samtidig med eller efter nylig brug af nefrotoksiske lægemidler.
That use of Truvada should be avoided with concomitant or recent use of nephrotoxic medicinal products.
At det er afgørende vigtigt nøje at overholde den ordinerede dosis og infusionshastighed.
That it is essential to follow strictly the prescribed dose and infusion rate
At det er den ordinerende læges ansvar at bestemme, hvilke patienter der kan være egnede til hjemme- eller selvbehandling med Fabrazyme.
That it is the responsibility of the prescribing physician to determine which patients may be suitable for home or self-administration of Fabrazyme.
At det er den ordinerende læges ansvar at sørge for passende uddannelse af ikke- sundhedspersonale som f.eks. patienter, der skal behandle sig selv, eller plejepersonale, der skal administrere behandlingen hjemme, hvis den behandlende læge bestemmer, at dette er hensigtsmæssigt.
That it is the responsibility of the prescribing physician to provide appropriate training to the non-healthcare professional, such as the patient for self-administration or a caregiver who will administer the treatment at home, if the treating physician decides that this is appropriate.
at det er den rigtige medicin
it is the right medicine
at det er den rigtige medicin.
it is the right medicine
At det er nødvendigt at monitorere hjertefrekvensen i 6 timer eller mere efter den første Gilenya-dosis inklusive måling af puls og blodtryk hver time.
That their heart rate will need to be monitored for 6 or more hours after the first dose of GILENYA, including hourly pulse and blood pressure checks.
at det er nødvendigt at tage højde for, at samtidig administration af voriconazol og REYATAZ uden ritonavir kan påvirke koncentrationen af atazanavir samtidig administration af fluticason og REYATAZ uden ritonavir kan øge koncentrationen af fluticason i forhold til administration af fluticason alene ved samtidig administration af et oralt kontraceptivum og REYATAZ uden ritonavir, anbefales det, at det orale kontraceptivum indeholder højst 30 µg ethinylestradiol dosisjustering af lamotrigin ikke er nødvendig
the need to consider that co-administration of voriconazole and REYATAZ without ritonavir may affect atazanavir concentrations co-administration of fluticasone and REYATAZ without ritonavir may increase fluticasone concentrations relative to fluticasone given alone if an oral contraceptive is administered with REYATAZ without ritonavir, it is recommended that the oral contraceptive contain no more than 30 µg of ethinyloestradiol no dose adjustment of lamotrigine is required
At det er vigtigt, at der monitoreres for kliniske tegn og symptomer på overfølsomhed, og at patienten skal kontakte lægen, hvis sådanne symptomer udvikles under eller efter administration af Ruconest.
The importance of monitoring for clinical signs and symptoms of hypersensitivity and that patients should alert their doctor if they develop such symptoms during or after receiving Ruconest.
at diagnosticere
diagnose kidney
At din læge eller sundhedsperson behandler evt. betændelse i såret – behandling med REGRANEX skal stoppes, hvis der kommer betændelse i såret.
Your doctor or healthcare professional treating any infection of the wound - treatment with REGRANEX should be stopped if the wound becomes infected
At din læge eller sundhedsperson fjerner det døde hud fra såret, når det er nødvendigt.
Your doctor or healthcare professional removing dead skin/debris from the wound whenever necessary
At disse sædvanligvis kun er en mindre gene for de fleste patienter.
these are only of nuisance value for most patients
At dosen er én gang dagligt
That the dose is once daily
At dosisjustering er nødvendig, når patienter skiftes fra den ene til den anden styrke:
That dose adjustment is needed when patients are switched from one to the other strength:
at drikke for meget alkohol et uregelmæssigt hjerteslag
drinking too much alcohol an irregular heartbeat
at du afgiver lidt eller intet urin hurtig hjerterytme.
passing little or no water (urine) fast heart beat.
At du bliver ved med at konsultere din læge eller sundhedsperson og følger din behandlingsplan.
Continuing to visit your doctor or healthcare professional and following your treatment plan
at du føler dig meget søvnig eller træt
feeling very sleepy or tired
at du har nok blodlegemer, og at din lever- og nyrefunktion er i orden.
you have enough blood cells, and your liver and kidneys are working properly.
at du lader meget lidt eller intet vand (urin)
passing little or no water (urine)
at du spiser mere, end din diæt tillader dig; eller feber, infektion eller følelsesmæssig ubalance.
eating a lot more than your diet allows; or fever, infection or emotional stress.
at du tager mindre insulin, end din læge har anvist;
taking less insulin than your doctor tells you to;
At du undgår unødig belastning/vægt på dine fødder, evt. ved at bære ortopædiske sko.
Keeping weight off your feet, perhaps by wearing special orthopaedic shoes or by other methods
At Emtricitabine/Tenofovir disoproxil Zentiva kun bør anvendes til patienter med nedsat nyrefunktion, hvis det vurderes, at de potentielle fordele opvejer de potentielle risici
That Emtricitabine/Tenofovir disoproxil Zentiva should only be used in patients with impaired renal function if the potential benefits are considered to outweigh the potential risks
At Erivedge ikke må videregives til andre personer
Not to give Erivedge to any other person
At Eurartesim er kontraindiceret hos patienter med svær malaria ifølge WHO-definitionen og hos patienter med tidligere kliniske tilstande, der kan føre til en forlængelse af QTc-intervallet, og hos patienter, der tager lægemidler, der er kendt for at forlænge QTc-intervallet.
That Eurartesim is contraindicated in patients with severe malaria according to WHO definition and in patients with a history of clinical conditions that may lead to QTc interval prolongation, and in patients taking drugs that are known to prolong the QTc interval.
At Eurartesim kan forlænge QTc-intervallet, hvilket kan føre til potentielt dødelige arytmier.
That Eurartesim has a potential to prolong the QTc interval that may lead to potentially lethal arrhythmias.
At evaluere forekomsten af følgende hos patienter, der behandles med lomitapid:
To evaluate the occurrence of the following in patients treated with lomitapide:
At fertile kvinder skal benytte effektiv prævention
That women of child bearing potential must use effective contraception
at forbedre din fysiske funktionsevne at bedre tegn og symptomer på børnegigt
improve your physical function improve signs and symptoms of polyarticular juvenile idiopathic arthritis
at forebygge dannelsen af blodpropper i blodkar i benene eller lungerne efter en ortopædisk operation (f.eks. i hofte eller knæ), eller efter en operation i maven.
prevent the formation of blood clots in the blood vessels of the legs or lungs after orthopaedic surgery (such as hip or knee surgery) or abdominal surgery
at forebygge dannelsen af blodpropper i blodkar i benene eller lungerne efter en ortopædisk operation (fx i hofte eller knæ), eller efter en operation i maven.
prevent the formation of blood clots in the blood vessels of the legs or lungs after orthopaedic surgery (such as hip or knee surgery) or abdominal surgery
At forebygge knoglekomplikationer, f.eks. knoglebrud hos voksne patienter med knoglemetastaser (spredning af kræft fra den primære kræftknude til knoglerne).
To prevent bone complications, e.g. fractures, in adult patients with bone metastases (spread of cancer from primary site to the bone).
At forebygge knoglekomplikationer, f.eks. knoglebrud, hos voksne patienter med knoglemeta- staser (spredning af kræft fra den primære kræftknude til knoglerne).
To prevent bone complications, e.g. fractures, in adult patients with bone metastases (spread of cancer from primary site to the bone).
at forebygge knoglekomplikationer, f.eks. knoglebrud, hos voksne patienter med knoglemetastaser (spredning af kræft fra den primære kræftknude til knoglerne).
to prevent bone complications, e.g. fractures, in adult patients with bone metastases (spread of cancer from primary site to the bone).
At forebygge knoglekomplikationer, fx knoglebrud, hos voksne patienter med knoglemetastaser (spredning af kræft fra den primære kræftknude til knoglerne).
To prevent bone complications, e.g. fractures, in adult patients with bone metastases (spread of cancer from primary site to the bone).
at forebygge slagtilfælde og blodpropper hos voksne, som har en unormal hjerterytme kaldet "ikke-valvulær atrieflimren", og som anses for at have risiko for slagtilfælde. at behandle dyb venetrombose (DVT, en blodprop i en dybtliggende vene, sædvanligvis i benet) og lungeemboli (en blodprop i et blodkar, som forsyner lungerne) og til at forebygge genkomst af DVT og lungeemboli hos voksne
to prevent stroke and the formation of clots in adults who have an abnormal heart beat called ‘non-valvular atrial fibrillation’ and are considered to be at risk of stroke; to treat deep vein thrombosis (DVT, a blood clot in a deep vein, usually in the leg) and pulmonary embolism (PE, a clot in a blood vessel supplying the lungs), and to prevent these conditions from reoccurring in adults.
At formålet med formularen til behandlingsstart er at give patienterne information om PML og IRIS
That the aim of the treatment initiation form is to provide patients with information on PML and IRIS
at forsinke skaden på dine led
low down the damage to your joints
at forsinke skaden på dine led at forbedre din fysiske funktionsevne
low down the damage to your joints improve your physical function
At føre en behandlingsdagbog
Keeping a treatment diary, and
at føre en behandlingsdagbog og hvad du skal gøre i tilfælde af alvorlige bivirkninger.
the keeping of a treatment diary, and measures to be taken in case of severe side effects.
At generiske lægemidler svarende til Zoledronsyre Teva er “generiske”, betyder, at de svarer til et “referencelægemiddel”, som allerede er godkendt i Den Europæiske Union (EU).
This means that Zoledronic acid Teva Generics is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aclasta.
At Gilenya er teratogent, og derfor skal kvinder i den frugtbare alder:
That GILENYA is teratogenic so women with childbearing potential must:
At Gilenya frarådes til patienter med:
That GILENYA is not recommended in patients with:
at give oplysninger om håndtering og minimering af antikolinerge reaktioner, navnlig håndtering af obstipation, urinretention, pneumoni, risiko for overophedning på grund af hæmmet svedafsondring, CNS-påvirkninger og overdosering, samt om allergiske reaktioner.
to provide information on the management and minimisation of anticholinergic reactions, especially on management of constipation, urinary retention, pneumonia, risk of overheating, CNS effects or overdose; and on allergic reactions.
At give patienterne tilstrækkelig information vedrørende sikker brug af lægemidlet;
To provide patients with appropriate information regarding the safe use of the product;
At gravide kvinder ikke må tage STAYVEER
That pregnant women must not take STAYVEER
At gravide kvinder ikke må tage Tracleer
That pregnant women must not take Tracleer
at gå ture eller foretag dig anden vægtbærende aktivitet at undgå rygning og for meget alkohol.
walking or any other weight-bearing exercise, not smoking; and not drinking too much alcohol.
at gå ture eller udøve anden vægtbærende aktivitet at undgå rygning og for meget alkohol
walking or other weight-bearing exercise not smoking and not drinking too much alcohol
at gå ture eller udøve anden vægtbærende aktivitet at undgå rygning og for meget alkohol.
walking or any other weight-bearing exercise not smoking; and not drinking too much alcohol
at gå ture eller udøve anden vægtbærende aktivitet at undgå rygning og for meget alkohol.
walking or other weight-bearing exercise not smoking and not drinking too much alcohol
at gå ture eller udøve anden vægtbærende aktivitet. at undgå rygning og for meget alkohol.
walking or any other weight-bearing exercise not smoking; and not drinking too much alcohol.
At halveringstiden ved de to sidstnævnte administrationsveje, navnlig halveringstiden ved oral administration, er længere end ved intravenøs administration, afspejler formodentlig glycopyrroniums komplekse absorption og fordeling ved disse to administrationsveje.
That the latter two half-lives, and especially that for oral administration, are longer than for i.v. administration probably reflects the complex absorption and distribution of glycopyrronium by each route.
At han ikke bør donere blod eller sæd under behandlingen og i en uge efter thalidomidbehandlingen afsluttes
That he should not donate blood or semen during therapy and for one week following discontinuation of thalidomide